Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
0.7570
Dollar change
+0.0140
Percentage change
1.88
%
Index- P/E- EPS (ttm)-0.50 Insider Own27.33% Shs Outstand81.90M Perf Week3.70%
Market Cap62.13M Forward P/E- EPS next Y-0.31 Insider Trans0.31% Shs Float59.64M Perf Month-25.05%
Income-35.32M PEG- EPS next Q-0.10 Inst Own7.76% Short Float0.81% Perf Quarter6.86%
Sales0.78M P/S79.65 EPS this Y25.33% Inst Trans-0.78% Short Ratio2.51 Perf Half Y4.36%
Book/sh-0.10 P/B- EPS next Y16.96% ROA-152.75% Short Interest0.48M Perf Year-54.94%
Cash/sh0.25 P/C3.00 EPS next 5Y- ROE-5396.85% 52W Range0.55 - 2.10 Perf YTD5.58%
Dividend Est.- P/FCF- EPS past 5Y2.75% ROI- 52W High-63.95% Beta1.36
Dividend TTM- Quick Ratio0.69 Sales past 5Y188.43% Gross Margin-82.07% 52W Low37.64% ATR (14)0.08
Dividend Ex-Date- Current Ratio0.69 EPS Y/Y TTM8.32% Oper. Margin-4641.76% RSI (14)37.81 Volatility10.68% 9.77%
Employees110 Debt/Eq- Sales Y/Y TTM153.04% Profit Margin-4555.53% Recom1.67 Target Price3.50
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q14.31% Payout- Rel Volume1.49 Prev Close0.74
Sales Surprise-49.65% EPS Surprise3.19% Sales Q/Q103.79% EarningsMar 26 BMO Avg Volume192.83K Price0.76
SMA20-15.71% SMA50-23.48% SMA200-25.97% Trades Volume287,530 Change1.88%
Date Action Analyst Rating Change Price Target Change
Feb-01-23Downgrade The Benchmark Company Buy → Hold
Feb-17-22Resumed Cantor Fitzgerald Overweight $8 → $7
Mar-10-21Initiated Cantor Fitzgerald Overweight $8
May-16-18Initiated Maxim Group Buy $6
May-14-18Reiterated The Benchmark Company Buy $7 → $5
Sep-07-16Reiterated Rodman & Renshaw Buy $12 → $10
Feb-01-16Initiated Rodman & Renshaw Buy $12
Mar-27-24 12:31PM
Mar-25-24 04:10PM
Mar-21-24 08:30AM
Mar-20-24 08:30AM
Mar-19-24 04:30PM
08:00AM Loading…
Feb-02-24 08:00AM
Jan-18-24 04:54AM
Jan-04-24 08:00AM
Dec-05-23 10:25AM
08:00AM
Nov-16-23 09:15AM
Nov-15-23 05:08AM
Nov-14-23 04:10PM
Nov-08-23 08:00AM
Nov-06-23 06:24AM
08:19AM Loading…
Nov-02-23 08:19AM
Oct-23-23 08:00AM
Oct-19-23 08:00AM
Oct-18-23 12:00PM
Oct-16-23 08:00AM
Oct-13-23 08:00AM
Oct-02-23 08:00AM
Sep-13-23 08:00AM
Aug-25-23 04:30AM
Aug-14-23 05:27PM
04:10PM
Aug-09-23 08:00AM
Jun-23-23 04:10PM
06:00AM
Jun-05-23 04:10PM
09:15AM Loading…
Jun-01-23 09:15AM
May-31-23 04:01PM
May-11-23 12:45PM
07:00AM
May-10-23 04:10PM
May-05-23 08:00AM
Apr-26-23 07:30AM
Apr-24-23 09:00AM
Mar-15-23 04:10PM
Mar-10-23 08:35AM
08:00AM
Mar-07-23 08:35AM
Mar-06-23 04:30PM
Feb-27-23 04:42AM
Feb-22-23 04:10PM
Feb-17-23 08:30AM
Feb-16-23 04:10PM
08:00AM
Jan-23-23 08:00AM
Jan-20-23 08:30AM
Jan-17-23 10:00AM
Jan-12-23 08:00AM
Jan-08-23 12:00PM
Dec-05-22 08:30AM
Nov-14-22 04:10PM
08:30AM
Nov-10-22 08:30AM
Nov-03-22 08:30AM
08:10AM
Oct-20-22 08:00AM
Oct-11-22 08:05AM
Oct-04-22 07:30AM
Sep-30-22 09:00AM
Sep-16-22 08:35AM
Sep-12-22 08:35AM
08:35AM
Aug-16-22 03:00PM
08:00AM
Aug-10-22 04:10PM
08:00AM
Aug-08-22 08:00AM
Aug-03-22 08:00AM
07:00AM
Aug-02-22 04:10PM
08:30AM
08:05AM
Jul-29-22 08:30AM
Jul-28-22 04:10PM
Jul-25-22 06:05AM
Jul-13-22 08:00AM
Jun-21-22 08:43AM
08:00AM
May-31-22 08:00AM
May-11-22 04:10PM
May-06-22 08:00AM
May-05-22 08:03AM
Apr-27-22 09:00AM
Apr-25-22 08:00AM
Apr-11-22 05:52AM
Apr-06-22 08:00AM
Mar-30-22 04:10PM
Mar-29-22 08:00AM
08:00AM
Mar-28-22 04:25PM
Mar-22-22 09:50AM
Mar-14-22 08:35AM
Mar-08-22 08:35AM
Mar-07-22 08:35AM
Feb-15-22 09:00AM
Feb-08-22 02:38PM
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eight Corp Ltd10% OwnerJan 02 '24Sale0.9020,00018,000298,419Jan 03 10:41 AM
Butera Salvatore ThomasCEO - Volition VeterinaryDec 18 '23Buy0.8310,0008,30099,350Dec 19 10:59 AM
Butera Salvatore ThomasCEO - Volition VeterinaryDec 15 '23Buy0.7710,0007,70089,350Dec 18 09:38 AM
Eight Corp Ltd10% OwnerDec 15 '23Sale0.7520,00015,000318,419Dec 20 10:31 AM
Rootsaert Rodney GerardSecretaryDec 13 '23Buy0.6010,0006,00078,652Dec 14 09:11 AM
Reynolds Cameron JohnPresident and CEODec 08 '23Buy0.6710,0006,7001,704,518Dec 11 08:51 AM
Innes Guy ArchibaldDirectorNov 27 '23Buy0.7720,00015,400627,161Nov 28 09:39 AM
Futcher EdwardDirectorNov 27 '23Buy0.809,0007,20071,936Nov 28 09:39 AM
Innes Guy ArchibaldDirectorNov 24 '23Buy0.7610,0007,600607,161Nov 27 10:28 AM
Innes Guy ArchibaldDirectorNov 22 '23Buy0.7120,00014,200597,161Nov 24 11:06 AM
Butera Salvatore ThomasCEO - Volition VeterinaryNov 16 '23Buy0.8110,0008,10079,350Nov 17 10:01 AM
Barnes PhillipDirectorSep 05 '23Buy1.305,0006,50024,686Sep 06 10:01 AM
Faulkes Martin CharlesDirectorAug 31 '23Buy1.289,71612,4361,673,532Sep 01 09:41 AM
Henshall MickieDirectorAug 31 '23Buy1.253,7064,63218,706Sep 19 04:05 PM
Micallef Jacob VincentChief Scientific OfficerAug 30 '23Buy1.278,75011,11255,000Aug 31 09:35 AM
Micallef Jacob VincentChief Scientific OfficerAug 29 '23Buy1.2411,25013,95046,250Aug 31 09:35 AM
Micallef Jacob VincentChief Scientific OfficerAug 25 '23Buy1.2420,00024,800235,140Aug 28 10:07 AM
Michel GaetanChief Operating OfficerAug 24 '23Buy1.235,0006,150212,997Aug 24 12:00 PM
Futcher EdwardDirectorAug 24 '23Buy1.225,0006,10062,936Aug 25 11:49 AM
Kway JasmineCEO - Singapore VolitionAug 24 '23Buy1.205,0006,00010,400Aug 25 11:49 AM
Reynolds Cameron JohnPresident and CEOAug 16 '23Buy1.2210,00012,2001,494,518Aug 16 12:28 PM
Butera Salvatore ThomasCEO - Volition VeterinaryAug 16 '23Buy1.218,0009,68069,350Aug 17 09:40 AM
Butera Salvatore ThomasCEO - Volition VeterinaryJun 02 '23Buy1.5910,00015,90061,350Jun 06 10:14 AM